跳至主要内容
临床试验/ACTRN12613000247774
ACTRN12613000247774已完成不适用

An investigation into the effects of two doses of glucose alone and a single dose of caffeine-glucose in combination on cognitive performance, fatigue and mood associated with extended multi-tasking in healthy adults aged 18-55 years

GlaxoSmithKline Nutritional Healthcare Future Group0 个研究点目标入组 160 人开始时间: 2013年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • 1.Male or female.
  • 2.Aged 18-55 years.
  • 3.Willing and able to provide written informed consent.
  • 4.Understands and is willing and able to comply with all study procedures.
  • 5.Are in good general health with no history of psychiatric disease.
  • 6.Regular caffeine consumers (between 1-4 cups of coffee per day)

排除标准

  • 1.Females who are pregnant, breast-feeding and/or not using a medically approved form of contraception.
  • 2.Any significant concurrent illness including any bleeding disorders, heart conditions, diabetes, glaucoma, high blood pressure or osteoporosis.
  • 3.Individuals who suffer from Diabetes Mellitus.
  • 4.Any known or suspected food allergies (this would cover all ingredients in the investigational product).
  • 5.Susceptible to any unwanted side-effects of caffeine, such as reduction in sleep quality.
  • 6.Smokers and users of recreational drugs (except alcohol and other food grade actives)
  • 7.Have participated in any other study involving an investigational product in the last 4 weeks.
  • 8.Those diagnosed with Phenyketonuria (PKU).

研究者

发起方
GlaxoSmithKline Nutritional Healthcare Future Group

相似试验